CD94 Monoclonal Antibody

Natural killer (NK) cells are a distinct lineage of lymphocytes that mediate cytotoxic activity and secrete cytokines upon immune stimulation. Several genes of the C-type lectin superfamily, including members of the NKG2 family, are expressed by NK cells and may be involved in the regulation of NK cell function. KLRD1 (CD94) is an antigen preferentially expressed on NK cells and is classified as a type II membrane protein because it has an external C terminus. Three transcript variants encoding two different isoforms have been found for this gene.

Introducing the CD94 Monoclonal Antibody, a cutting-edge scientific innovation designed to revolutionize the field of immunology. This meticulously crafted product showcases unparalleled precision and efficacy, offering researchers and medical professionals an invaluable tool for their investigative endeavors.

The CD94 Monoclonal Antibody is meticulously engineered using state-of-the-art technology, ensuring the highest level of specificity and sensitivity. Its exceptional binding affinity to the CD94 antigen enables accurate identification and characterization of target cells, facilitating a deeper understanding of immune responses and cellular interactions.

With its exceptional performance, this antibody empowers researchers to unravel the intricate mechanisms underlying immune system regulation, paving the way for groundbreaking discoveries in immunotherapy, vaccine development, and disease pathogenesis. Its versatility extends to a wide range of applications, including flow cytometry, immunohistochemistry, and western blotting, providing researchers with a comprehensive toolkit to explore diverse research avenues.

The CD94 Monoclonal Antibody boasts exceptional reproducibility and reliability, ensuring consistent and robust results across experiments. Its superior quality and stringent manufacturing processes guarantee batch-to-batch consistency, eliminating any potential variability and ensuring the utmost confidence in experimental outcomes.

Furthermore, this antibody is meticulously validated through rigorous testing procedures, adhering to the highest industry standards. Its exceptional performance is demonstrated through its ability to detect even the most minute quantities of the CD94 antigen, enabling researchers to delve into the intricacies of immune cell populations with unparalleled precision.

In addition to its scientific prowess, the CD94 Monoclonal Antibody is packaged in a user-friendly format, facilitating seamless integration into laboratory workflows. Its clear and concise instructions enable effortless handling, ensuring researchers can focus on their investigations without any unnecessary complications.

In summary, the CD94 Monoclonal Antibody represents a groundbreaking advancement in immunological research. Its exceptional specificity, sensitivity, and versatility make it an indispensable tool for researchers and medical professionals alike. With its unwavering reliability and reproducibility, this antibody is poised to redefine the boundaries of immunology, unlocking new avenues of scientific exploration and paving the way for transformative discoveries in the field.